Search results

Private biotech company focused on developing modulators of intracellular protein-protein interactions employing a proprietary technology platform. The most advanced of these first-in-class therapeutics, an oral modulator of dysregulated transcription, is currently in preclinical development.

We specialise in research products and diagnostics, with focus on molecular controls, calibrators for nucleic acid testing, controls for many commercial molecular systems and a large archive of clinical specimens and wide range of seroconversion material from HIV, HCV, HBV asymptomatic donors.

FGen is an emerging Swiss biotech company active as a contract research organization in strain development and optimization. Key technologies are methods for biological engineering, such as Synthetic Biology or non-GMO methods, and a proprietary screening platform for high throughput screening. In 2022 was ac

As a global market leader in depth filtration we offer complete solutions for filtration of high value liquids. Since 1938 we are experts in development, manufacturing of filter media and equipment and supply of high quality products for applications in pharma, biotech, chemicals, cosmetics and F&B.

We are a service provider for pharma, biotech and academia specialized in analyzing protein-protein interactions using LC-MS/MS. Especially identifying targets and off-targets of drugs and identify new drug targets on living cell (LRC-TriCEPS).

The group, offering state-of-the-art regenerative medicine solutions, has developed a technology platform that gave birth to therapies aiming at tissue regeneration across different applications, in order to provide pertinent and sustainable solutions leveraging the human's natural endowment.

Biognosys provides next generation proteomics technology to quantify thousands of proteins for biomarker discovery or mode of action studies. The technology is available to researchers worldwide through our contract research services or our innovative reagent and software products. Biognosys was acquired by B

Biolytix is headquartered in Switzerland and aims to be a leading partner for microbiological and molecular biology analyzes. Biolytix works with clients in all major international markets and strives to have a leading position in its core competencies.

BC Platforms is a world leader in providing powerful genomic data management solutions to address some of the biggest healthcare challenges today by leveraging the convergence of genomics and healthcare information technologies.

At Beckman Coulter, we are dedicated to advancing and optimizing the laboratory. For more than 80 years, we have been a trusted partner for laboratory professionals, helping to advance scientific research and patient. More than 275,000 Beckman Coulter systems operate in labs around the world.

B'SYS GmbH is a leading European Ion Channel CRO and has a comprehensive library of validated human ion channel expressing cell lines. The services include: Automated and manual patch-clamping, cell line design, and test system generation, GLP-certified cardiac safety testing.

AlloCyte Pharmaceuticals AG is a Swiss-based company discovering, developing and commercializing next generation oral integrin modulators of allosteric mode of action protecting the integrity of tissues afflicted by autoimmunity. The next target milestone is clinical therapeutic proof-of-concept.

4D Lifetec has developed an easy-to-use blood test consisting of a patented RO platform technology and a proprietary immuno-biomarker to detect DNA degradation early. A protected AI enables high-throughput analysis. The assay successfully passed first clinical documentation for both oncology and longevity app

Our efficient development team of computer scientists provides the basic functionalities for the customer solutions to our project managers. Based on the basic functionalities, our highly qualified project management team converts the customers’ needs into perfect software solutions.

Abionic has developed a revolutionary nanofluidic technology providing professionals a unique and ultra-fast point of care diagnostic tool allowing immediate access to results for a large panel of blood tests. Abionic has developed the fastest sepsis test to identify people at risk to develop sepsis.